Iridex (IRIX) EPS (Weighted Average and Diluted) (2016 - 2025)
Iridex (IRIX) has 16 years of EPS (Weighted Average and Diluted) data on record, last reported at -$0.09 in Q3 2025.
- For Q3 2025, EPS (Weighted Average and Diluted) rose 25.0% year-over-year to -$0.09; the TTM value through Sep 2025 reached -$0.3, up 55.88%, while the annual FY2024 figure was -$0.54, 8.47% up from the prior year.
- EPS (Weighted Average and Diluted) reached -$0.09 in Q3 2025 per IRIX's latest filing, down from -$0.06 in the prior quarter.
- Across five years, EPS (Weighted Average and Diluted) topped out at $0.1 in Q1 2022 and bottomed at -$0.29 in Q4 2022.
- Average EPS (Weighted Average and Diluted) over 5 years is -$0.12, with a median of -$0.13 recorded in 2023.
- Peak YoY movement for EPS (Weighted Average and Diluted): crashed 390.0% in 2022, then soared 72.22% in 2024.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.14 in 2021, then plummeted by 107.14% to -$0.29 in 2022, then surged by 37.93% to -$0.18 in 2023, then skyrocketed by 72.22% to -$0.05 in 2024, then plummeted by 80.0% to -$0.09 in 2025.
- Per Business Quant database, its latest 3 readings for EPS (Weighted Average and Diluted) were -$0.09 in Q3 2025, -$0.06 in Q2 2025, and -$0.1 in Q1 2025.